Last reviewed · How we verify
IL-YANG Trivalent Influenza Vaccine
IL-YANG Trivalent Influenza Vaccine is a Inactivated influenza vaccine Biologic drug developed by Il-Yang Pharm. Co., Ltd.. It is currently in Phase 3 development for Seasonal influenza prevention in adults and children.
IL-YANG Trivalent Influenza Vaccine stimulates the immune system to produce antibodies and cellular immunity against three strains of influenza virus.
IL-YANG Trivalent Influenza Vaccine stimulates the immune system to produce antibodies and cellular immunity against three strains of influenza virus. Used for Seasonal influenza prevention in adults and children.
At a glance
| Generic name | IL-YANG Trivalent Influenza Vaccine |
|---|---|
| Sponsor | Il-Yang Pharm. Co., Ltd. |
| Drug class | Inactivated influenza vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
This inactivated influenza vaccine contains antigens from three circulating influenza virus strains (typically two A subtypes and one B type). Upon administration, it triggers both humoral (antibody-mediated) and cellular immune responses, enabling the body to recognize and neutralize these specific influenza strains if encountered naturally. The vaccine reduces infection risk and severity of illness in vaccinated individuals.
Approved indications
- Seasonal influenza prevention in adults and children
Common side effects
- Injection site pain, redness, or swelling
- Myalgia (muscle pain)
- Headache
- Fatigue
- Low-grade fever
Key clinical trials
- Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.' (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IL-YANG Trivalent Influenza Vaccine CI brief — competitive landscape report
- IL-YANG Trivalent Influenza Vaccine updates RSS · CI watch RSS
- Il-Yang Pharm. Co., Ltd. portfolio CI
Frequently asked questions about IL-YANG Trivalent Influenza Vaccine
What is IL-YANG Trivalent Influenza Vaccine?
How does IL-YANG Trivalent Influenza Vaccine work?
What is IL-YANG Trivalent Influenza Vaccine used for?
Who makes IL-YANG Trivalent Influenza Vaccine?
What drug class is IL-YANG Trivalent Influenza Vaccine in?
What development phase is IL-YANG Trivalent Influenza Vaccine in?
What are the side effects of IL-YANG Trivalent Influenza Vaccine?
Related
- Drug class: All Inactivated influenza vaccine drugs
- Manufacturer: Il-Yang Pharm. Co., Ltd. — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Seasonal influenza prevention in adults and children
- Compare: IL-YANG Trivalent Influenza Vaccine vs similar drugs
- Pricing: IL-YANG Trivalent Influenza Vaccine cost, discount & access